뉴욕의 자가면역질환 임상 시험
자가면역질환 관련 연구 24개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1036, New York
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
- Children's Hospital at Montefiore - Accepting Young Adult and Juvenile Patients, The Bronx
피험자 모집 중2/3상
6세 ~ 75세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology, Great Neck
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07103746Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03816345Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- St Lawrence Health System, Potsdam
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07621809A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06722235A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중1상
18세 ~ 74세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06948318Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- Columbia University Irving Medical Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT06626919A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- NY Cancer and Blood Specialists, Shirley
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07059000Daratumumab in Primary Antiphospholipid Syndrome
- Northwell Health, Great Neck
- NYU Langone, New York
- Hospital for Special Surgery, New York
- 외 1개
피험자 모집 중1/2상
18세 ~ 65세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05671757RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Columbia University, New York
- University of Rochester Medical Center, Rochester
피험자 모집 중1/2상
18세 ~ 70세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06359041RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Columbia University Irving Medical Center, New York
- University of Rochester, Rochester
피험자 모집 중2/3상
18세 ~ 75세 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT06328777A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Columbia University, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT04422912RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
피험자 모집 중1/2상
12세 ~ 65세 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT06121297A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
피험자 모집 중2상
16세 ~ 70세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07328581A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06572384Abatacept for the Treatment of Giant Cell Arteritis
- Hospital for Special Surgery, New York
피험자 모집 중3상
50세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT04474847Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- NY Nephrology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06858319Autoimmune and Autoinflammatory Genetics Study
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
피험자 모집 중관찰 연구건강한 지원자 환영
1 Month · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT06004349A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- 외 9개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
피험자 모집 중1상
12세 ~ 70세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06308978Biologics And Clinical Immunology Cohort at Sinai
- Mount Sinai, New York
피험자 모집 중관찰 연구
12세 이상 · 모든 성별 · 2026. 2. 17. 업데이트됨 · NCT04784364Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
피험자 모집 중관찰 연구건강한 지원자 환영
99세 이하 · 모든 성별 · 2026. 2. 4. 업데이트됨 · NCT05584488ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.